Riboksin: malangizo ntchito, ikulongosola za katundu.

Mankhwala "Riboxinum" malangizo pa ntchito limanena kuti mankhwala ali ndi kutchulidwa antihypoxic ndi antiarrhythmic kanthu. Kutenga gawo mwachindunji mu kagayidwe shuga mu thupi la munthu, izo kumathandiza kuti ndondomeko ya kuwombola ake pa nthawi ya hypoxia. Komanso, mankhwala timapitiriza njira kagayidwe kachakudya mu zimakhala za minofu mtima, bwino minofu kupuma ndi bwino mtima contractile ntchito myocardium lapansi.

Maonekedwe a mankhwala "Riboksin" umboni limanena kuti filimu TACHIMATA miyala kukhala mtundu kuyambira kuwala zachikasu kuwala lalanje. Pang'ono akhakula pamwamba, ndi otukukira kunja mawonekedwe. Waukulu yogwira pophika mu zikuchokera mankhwala "Riboksin" ndi inosine.

Mankhwala "Riboksin": zikuonetsa ntchito ndi mlingo.

medicament akhoza okhawo pa mankhwala, ntchito palokha kwathunthu mulibemo. Mu ophatikizana mankhwala "Riboksin" malangizo Buku akuonetsa kumwa pa:

• Inu kobadwa nako ndi kuthi zopindika mtima ;
• Inu matenda enaake;
• Inu aakulu pachimake chiwindi;
• Inu m'mnyewa wamtima;
• Inu arrhythmia anakhala zotsatira achire makonzedwe mtima glycosides;
• Inu myocarditis;
• Inu inatsekeratu insufficiency;
• Inu m'mnyewa wamtima infarction;
• Inu «mtima m'mapapo mwanga";
• Inu a arrhythmias mtima.

Izo analimbikitsanso ntchito yokonza monga njira farmakozaschity pamene tikugwira ntchito iliyonse pa impso lakutali.

Mu nkhani ya mlingo wa mankhwala "Riboksin" malangizo Buku akuonetsa malangizo otsatirawa. Woyamba limodzi kapena masiku awiri kuyambira chithandizo ayenera kuchepetsa kadyedwe 1 kapisozi kapena matabuleti 3-4 pa tsiku. Ngati si wapezeka zizindikiro zilizonse matupi awo sagwirizana ndi zochita, mlingo kuti chiyambi cha tsiku lachitatu kuwonjezeka, zikubweretsa magalamu 2-2.4 patsiku. Inde phwando medicament chimakhala cha miyezi wina anayi ndi kuvomerezedwa zochita zachipatala kulamulira kwa mankhwala. "Riboxinum" malangizo Buku akuonetsa kumwa pamaso ingestion, zomwe zimalimbikitsa mayamwidwe pachimake.

Mankhwala "Riboksin": contraindications, ambiri osokoneza ndi malangizo.

Popeza mankhwala ntchito pa kuphatikiza mankhwala a matenda a mtima, kufunika wapadera ndi ngakhale wake ndi mankhwala ena. Pamene jakisoni "Riboxinum" ali osavomerezeka kusakaniza izo mu syringe chomwecho ndi mankhwala ena aliwonse, ngati zimenezi zingayambitse osadziwika mankhwala anachita. Pa nthawi yomweyo kutenga mankhwala ndi mtima glycosides zotsatira zawo kuphatikiza zotsatira kupewa wa arrhythmias mtima. Β-adrenergic blockers musati kuchepetsa zotsatira akangofika mankhwala "Riboxinum", ntchito yawo pa nthawi yomweyo kuloledwa.

Contraindications kulandira mankhwala ndi hyperuricemia, gout, ndi kukhalapo mu mtima wa tsankho payekha kapena hypersensitivity kwa zigawo zikuluzikulu za mankhwala. Pankhani ya kulephera wodwala aimpso kufunika mankhwala ayenera kumwedwa kokha pamene pali zizindikiro kwambiri. The wonse wa mankhwala n'kofunika kuti aziona impso ntchito.

Milandu "Riboksin" ambiri osokoneza sizinachitike chizindikiro, zizindikiro sakudziwika. Pamene mavuto anati, thupi lawo siligwirizana mu mawonekedwe a kuyabwa, pachimake gout, mwapadera - nyamuka lakuthwa madzi a magazi urea. Ndi chitukuko cha mphamvu ya mankhwala ayenera anasiya. Gwiritsani ntchito njira mwadzidzidzi chilango kuphwanya ntchito mtima sikuloledwa.